Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure
- PMID: 6182786
- DOI: 10.1016/0002-9149(82)90403-9
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure
Abstract
The coronary hemodynamic effects of vasodilator therapy with angiotensin-converting enzyme inhibitors (captopril and teprotide) were studied in 11 patients with ischemic heart disease and severe congestive heart failure (CHF). Over 2 hours, systemic vascular resistance was reduced from 2,408 +/- 240 to 1,715 +/- 170 dynes . s . cm-5 (p less than 0.001), and cardiac output improved 18%, resulting in lower arterial pressure (101 +/- 8 to 86 +/- 5 mm Hg, p less than 0.001) and left ventricular filling pressure (30 +/- 2 to 21 +/- 2 mm Hg, p less than 0.001). Coronary sinus thermodilution blood flow paralleled perfusion pressure but did not significantly vary overall (160 +/- 20 to 133 +/- 12 ml/min, difference not significant [NS]). Coronary vascular resistance was unchanged. Although the left ventricular stroke work index rose slightly (37.7 +/- 8.8 to 41.3 +/- 7.9 g l m/m2, p less than 0.05), there was no change in the coronary arteriovenous oxygen content difference (10.8 +/- 1.0 to 10.4 +/- 1.0 ml/10 ml, NS) or calculated myocardial oxygen consumption (16.4 +/- 1.9 to 13.9 /- 1.6 ml/min, NS). The heart rate-systolic blood pressure product declined significantly during this period (8,824 +/- 703 to 7,087 +/- 514 beats . mm Hg, p less than 0.02); this relief of cardiac effort was a function of the pretreatment plasma renin activity. A derived index of external myocardial efficiency improved 37% (19 +/- 3 to 26 +/- 6, p less than 0.05), reflecting greater left ventricular work without increased oxygen demand. Enhancement of myocardial performance after converting enzyme inhibition appears dependent on reduction of angiotensin-mediated ventricular afterload and preload. The lack of coronary vasomotor effects in patients with advanced ischemic cardiomyopathy may reflect limited coronary vascular reserve. Improvement of heart failure in these patients developed without evidence of myocardial ischemia, since balance was maintained between oxygen supply and demand.
Similar articles
-
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004. Drugs. 1984. PMID: 6205842 Review.
-
Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.Am J Med. 1984 May 31;76(5B):104-10. doi: 10.1016/0002-9343(84)90895-7. Am J Med. 1984. PMID: 6203405
-
Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.Am J Cardiol. 1982 Apr 21;49(6):1480-3. doi: 10.1016/0002-9149(82)90364-2. Am J Cardiol. 1982. PMID: 6176108
-
Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation. 1978 Nov;58(5):770-6. doi: 10.1161/01.cir.58.5.770. Circulation. 1978. PMID: 699246
-
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.Drugs. 1983 Jan;25(1):6-40. doi: 10.2165/00003495-198325010-00002. Drugs. 1983. PMID: 6218982 Review.
Cited by
-
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004. Drugs. 1984. PMID: 6205842 Review.
-
The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.Br Heart J. 1989 Aug;62(2):112-7. doi: 10.1136/hrt.62.2.112. Br Heart J. 1989. PMID: 2548548 Free PMC article. Clinical Trial.
-
Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.Cardiovasc Drugs Ther. 1996 Nov;10 Suppl 2:639-47. doi: 10.1007/BF00052511. Cardiovasc Drugs Ther. 1996. PMID: 9115958 Review.
-
Cardiac effects of angiotensin converting enzyme inhibitors.Cardiovasc Drugs Ther. 1990 Feb;4(1):243-5. doi: 10.1007/BF01857639. Cardiovasc Drugs Ther. 1990. PMID: 2285617 Review.
-
ACE inhibitors for the treatment of myocardial ischemia?Cardiovasc Drugs Ther. 1990 Oct;4(5):1375-84. doi: 10.1007/BF02018265. Cardiovasc Drugs Ther. 1990. PMID: 2278872 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous